Study Objective: To assess the association between sleep-disordered breathing and cognitive functioning in an elderly cohort of JapaneseAmerican men Design: Cross-sectional study Setting: The Honolulu-Asia Aging Study of Sleep Apnea, Oahu, Hawaii Participants: 718 men between 79 and 97 years of age examined in 1999 and 2000 Measurements: Apnea-hypopnea index from in-home overnight polysomnography, performance on the Cognitive Abilities Screening Instrument, body mass index, neck circumference, Epworth Sleepiness Scale, snoring, Center for Epidemiologic Studies Depression 11-item depression scale, physical disability, and history of heart disease, stroke, hypertension, diabetes, and dementia. Results: Less than 30% of the men had no sleep-disordered breathing (apnea-hypopnea index < 5) and nearly one-fifth (19%) had severe sleepdisordered breathing (apnea-hypopnea index > 30). Severe sleep-disordered breathing was associated with higher body mass index, habitual snoring, and daytime drowsiness. No association was found between sleep-disordered breathing and cognitive functioning, including measures of memory function, concentration, and attention. Conclusions: Sleep-disordered breathing was associated with more drowsiness but not with poor performance on standardized cognitive tests used to screen for Alzheimer disease and other dementias in older persons. Because a healthy-participant effect may have contributed to this finding, more extensive cognitive testing may be necessary to reveal more subtle deficits from sleep-disordered breathing.
INTRODUCTION

EPIDEMIOLOGIC STUDIES, PRIMARILY IN MIDDLE-AGED ADULTS, HAVE SHOWN ASSOCIATIONS BETWEEN SLEEP-DIS-ORDERED BREATHING (SDB) AND DEFICITS IN NEUROPSY-CHOLOGIC FUNCTION, PARTICULARLY ATTENTION AND
CONCENTRATION. 1, 2 Repeated episodes of oxygen desaturation and poor sleep efficiency in SDB may play roles in causing cognitive impairment and, possibly, encephalopathy. 3, 4 In the Wisconsin Cohort Study of 841 men and women between 30 and 60 years of age, an elevated apneahypopnea index (AHI) was associated with deficits in psychomotor efficiency, and the authors estimated that an AHI of 15 was equivalent to a decrement in psychomotor efficiency associated with 5 additional years of age. 1 In a matched case-control study of extensive neuropsychologic testing among 32 adults with mild SDB (AHI between 10 and 30) compared with 20 controls, cases performed worse on a visual vigilance task and a test of working memory but did not differ in other memory-related and executive function tasks, suggesting only a very modest decline in neuropsychologic function among those with mild SDB. 2 Both the prevalence of SDB and mild cognitive impairment increase dramatically with age, 5, 6 but few epidemiologic studies have assessed the relationship between these disorders in large community-based older populations. 3, 7 The Honolulu-Asia Aging Study of Sleep Apnea (HAASSA) was conducted to assess SDB in an elderly cohort of Japanese-American men under surveillance for Alzheimer disease (AD) and other dementias. 8 Subjects had unattended overnight polysomnography (PSG) conducted in their home according to criteria established previously for the large multicenter Sleep Heart Health Study (SHHS). 9 The protocol (conducted in 1999-2000) was added to the Honolulu-Asia Aging Study (HAAS), a longitudinal study of AD and other aspects of brain aging among surviving participants of the Honolulu Heart Program (HHP). 10, 11 More than 700 men aged 79 years and older were screened for dementia and received overnight PSG during the course of the 1999-2000 examination. These cross-sectional data were used to assess possible relationships between SDB and cognitive performance in late life.
METHODS
The HHP began in 1965 as an epidemiologic cohort study of cardiovascular disease among 8,006 middle-aged Japanese-American men. 12 The first 3 HHP examinations were conducted between 1965 and 1974. The HAAS of dementia began in 1991 as part of a fourth HHP examination among 3,734 survivors. Screening for dementia was based on the Cognitive Abilities Screening Instrument (CASI), a standardized instrument developed for cross-cultural epidemiologic studies of dementia. 13 Confirmation of dementia and its underlying causes were based on standardized neurologic evaluations of those who screened positive for cognitive impairment. 10 Three more examinations representing the fifth, sixth, and seventh HHP examinations, conducted in 1994-1996, 1997-1999, and 1999-2000 , respectively, identified incident cases of dementia, and an eighth examination is currently in progress.
A total of 1,523 men participated in the seventh HHP examination. Men with an existing diagnosis of moderate or more severe dementia (N=32) based on the Clinical Dementia Rating (CDR) 14 were not recruited for PSG. In addition, recruitment for PSG excluded participants who were currently either receiving continuous positive airway pressure treatment for sleep apnea or on oxygen therapy (N=9). Among the remainder, 718, ranging in age from 79 to 97 years, successfully completed an overnight PSG, representing a 49% response rate. Only 6 out of 80 persons with mild dementia consented to PSG and were excluded from the analyses of SDB. The response rate declined significantly with increasing age, from 55% among those 79 to 84 years of age, to 41% in those 85 to 89 years, and to a low of 25% among those 90 years and older. The average recording time was more than 9 hours, and more than 94% of the sleep studies were considered of good or better quality because at least 1 respiratory channel (airflow or thoracic band), oximetry, and 1 electroencephalographic recording were recorded for at least 5 hours.
The CASI, a 20-to 30-minute assessment, provides quantitative data on 9 cognitive domains: attention, concentration, orientation, short-and long-term memory, language abilities, visual construction, list-generating fluency, abstraction, and judgment. Scores range from 0.0 to 100.0, with a lower score indicative of poorer performance. Because the CASI is a composite of the Hasegawa Dementia Screening Scale (widely used in epidemiologic studies in Japan), the Folstein Mini-Mental State Examination (MMSE), and the Modified MMSE, equivalent scores for these assessments can be derived from a subset of the questions. 13 The short-term memory subcomponent score ranges from 0 to 12 and is based on an immediate recall of 3 words, a second delayed recall of the 3 words, and a recall of 5 objects that are shown to the subject. The attention subcomponent score ranges from 0 to 8 and is based on repeating 3 words and repeating 2 sentences. The concentration subcomponent ranges from 0 to 10 and is based on repeating several digits backward and a serial subtraction of 3's from the number 100. 12 The brief shortterm memory, attention, and concentration CASI subcomponent scores were analyzed separately because they presumably correlate best with the more extensive cognitive tests linked to performance deficits in middle-aged adults with SDB.
The CASI scores from the seventh examination typically were obtained in the home of those undergoing PSG and in the clinic for the men who refused an overnight sleep study. Persons with a CASI score less than 70 were referred for standardized neurologic examinations to confirm a diagnosis of dementia and its underlying cause. This cutpoint for incidence evaluation has a sensitivity of approximately 85% and a specificity of approximately 90%, based on previous assessments of the CASI. A cutpoint of less than 74 was used in the baseline screening for prevalence. Dementia was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, third edition, revised (DSM-III-R). 15 The protocol for conducting and scoring the sleep studies followed the criteria of the SHHS that had previously validated single-night homebased PSG for a large multicenter study of cardiovascular disease among adults aged 40 years and older. 9, 16 The PSG was conducted with a Compumedics PS-2 system (Compumedics Pty Ltd., Abbotsford, Australia) with the following montage: central electroencephalogram (C 4 /A 1 and C 3 /A 2 ), right and left electrooculogram, chin electromyogram, a single bipolar electrocardiogram, finger pulse oximetry, chest and abdominal excursion by respiratory inductance plethysmography, airflow by oronasal thermocouples, body position, and ambient light. Sensors were placed and equipment was calibrated during an evening home visit by centrally trained and certified technicians. Data were stored in real time on PCMCIA cards and equipment was retrieved the next day.
Severity of SDB is based on the AHI. The AHI represents the number of apneic and hypopneic episodes per hour of sleep derived from the overnight readings. Each apnea episode (complete or nearly complete cessation of airflow) and each hypopnea episode (at least a 30% decrease in airflow or thoracoabdominal excursion from baseline for 10 seconds or more) was accompanied by at least a 4% decrease in oxygen saturation. Subjects with an AHI of 30 or more were categorized as having severe SDB, and those with an AHI less than 5 were categorized as having no SDB. Mild and moderate SDB were based on an AHI ranging from 5 to 14, and from 15 to 29, respectively.
The Epworth Sleepiness Scale (ESS) was used to measure daytime drowsiness. Subjects reported their chance of dozing as never (score=0), slight (score=1), moderate (score=2), or high (score=3) in 8 circumstances, including sitting and reading, watching TV, sitting inactive in a public place (theater, meeting), as a passenger in a car for an hour or longer, when lying down to rest in the afternoon when circumstances permit, when sitting and talking to someone, when sitting quietly after lunch without alcohol, and in a car while stopped for a few minutes in traffic. 17 Scores ranged from 0 to 24, and those with an ESS score greater than 10 were categorized as having daytime drowsiness. Persons who reported often or almost always snoring loudly were categorized as habitual snorers. Neck circumference was measured in centimeters and body mass index (BMI) was computed as the ratio of weight measured in kilograms over the square of height in meters (height was measured in the fourth examination).
Depressed mood was based on an abbreviated 11-item version of the 20-item CES-D scale and can range from 0 (indicating no symptoms) to a maximum score of 33. Abbreviated versions of the CES-D scale have been shown to identify those in a population with depressive symptomatology equally as well as the full instrument when using a modified cutpoint. 18 In this case, those with scores greater than 8 (versus 16 for the full instrument) were categorized as having depressed mood. 19 Age and marital status were ascertained in the seventh HHP examination and years of education were ascertained in the fourth HHP examination. Data from the sixth HHP examination, conducted approximately 1.5 years earlier, were used to categorize those with difficulty in instrumental activities of daily living (IADLs) including shopping, preparing meals, managing money, and using the phone, or in activities of daily living (ADLs) including feeding, dressing, bathing, and using the toilet. 20, 21 Diagnosis of coronary heart disease (CHD) and stroke was based on self-reported data in the sixth HHP examination and by clinical record from the HHP cardiovascular disease surveillance data complete through 1997. Diagnosis of diabetes was based on self-report of a physician's diagnosis or the use of medication or insulin to treat diabetes at the time of the seventh HHP examination. Hypertension was based on the participant's use of antihypertensive medications, including β-adrenergic Statistical analyses included correlation analyses for continuous measures, χ 2 tests for association between categorical measures, and t-tests from general linear models for continuous and categorical associations with the various dependent cognition scores. Multiple logistic regression models were used to assess selected dichotomous variables in association with categories of exposure and adjustment for other factors. All subjects consented to participation in the seventh examination, and all protocols are in accordance with the Institutional Review Board of the Kuakini Medical Center and the Pacific Health Research Institute.
RESULTS
Subjects agreeing to PSG were younger, more likely to have a highschool education, more likely to be married, and more likely to snore ( Table 1) . The PSG subjects, however, were less likely to have difficulty with IADLs and basic ADLs and less likely to have depressed mood and poor cognition, and very few (N=6) had a history of dementia. In contrast, diagnoses of stroke, CHD, hypertension, and diabetes were comparable between participants and nonparticipants.
Among the 712 nondemented participants undergoing PSG, 204 men (29%) had no SDB (AHI<5) and 132 men (19%) had severe SDB (AHI > 30). The remainder (53%) had mild to moderate SDB (AHI=5-29). Severe SDB was associated with elevated BMI, habitual snoring, and daytime drowsiness (Table 2) . No association was found between severe SDB and cognitive impairment indicated by a CASI score less than 74 (12%) or a history of stroke (3%), CHD (10%), hypertension (63%), and diabetes (26%). Severe SDB also was not associated with depressed mood (10%) or with physical frailty (25%), indicated by difficulty in IADLs or basic ADLs.
The CASI score, the equivalent MMSE score, and the CASI's subcomponent scores for memory, attention, and concentration were not associated with level of SDB (Table 3 ). In addition, after adjusting for differences in age, education, and marital status, the 98 men who scored less than 74 on the CASI (14% of the PSG participants) showed no significant differences in several other aspects of their sleep compared to men with higher scores. This included the percentage of sleep time spent in apneas and hypopneas (27.9% in CASI<74 vs 25.4% in higher CASI), their average number of arousals per hour (25.5 vs 24.4), and their odds for having more than 10% of their sleep time with an oxygen saturation less than 90%, which occurred in approximately 10% of the sleep studies (odds ratio=1.64, 95% confidence interval=0.86-3.14). Although men with a low CASI had an equivalent mean time spent asleep compared with men having higher CASI scores (5.9 hours), they spent 20 minutes more time in bed, on average, and consequently had a significantly lower mean sleep efficiency computed as the ratio of time asleep over time in bed, 64% in men with CASI less than 74 versus 69% among men with higher CASI (P< .05). In addition, their odds for having more than 1 central apnea per hour was increased by 65%, but this increased risk was of borderline statistical significance (odds ratio =1.65, 95% confidence interval =0.99-2.74).
Low CASI score (<74) was not associated with daytime drowsiness (ESS score >10) in these nondemented men who underwent sleep studies. Similarly, among the nondemented men who refused overnight PSG, low CASI score was not associated with drowsiness. However, among the 113 men with a diagnosis of dementia at the time of the seventh examination (mean CASI score= 43.6), the demented persons with drowsiness (36% of cases) had a significantly lower mean CASI score (35.5) compared with nondrowsy demented persons who had a mean CASI score of 45.4 (P< .05). Thus, daytime drowsiness was associated with worse performance on the CASI in demented persons only.
DISCUSSION
Severe SDB was common (19%) among these elderly JapaneseAmerican men. This high prevalence may be related to their advanced age (80 years and older) and to their ethnicity, as both factors have been linked to an increased risk. 6, 22 Persons with SDB were more likely to have a higher BMI, habitually snore, and have more daytime drowsiness (ESS>10) as found in other studies . 23, 24 In contrast, severe SDB was not associated with prevalent hypertension, CHD, or stroke, as has been found in younger-aged populations. For example, in the SHHS cohort of more than 6,000 men and women aged 40 years and older, cross-sectional results showed that SDB was associated with hypertension, although it was a modest association that was not significant among subjects aged 65 years and older. 25 In addition, SDB in the SHHS was only modestly associated with CHD. 26 In this study, self-reported history of stoke or CHD was not associated with SDB, and limiting the analyses to only those identified by surveillance for cardiovascular disease through 1997 (3% with stroke and 13% with CHD) did not alter the findings of no association with these conditions. Measures of cognitive function in the SHHS also were not associated with SDB. 27 The SHHS data were from a younger cohort of both men and women ranging from 53 to 74 years of age and used different cognitive tests that took a similar amount of time to complete as the CASI, approximately 20 to 30 minutes. The median AHI among the SHHS men who were cognitively tested was 6.2 compared with a median AHI of 11.1 in this cohort of very old JapaneseAmerican men.
Studies have shown deficits in neurobehavioral function among patients with SDB. However these deficits are less severe than are the cognitive deficits measured in patients with onset of AD. The lack of an association between SDB and performance on a brief screening instrument for cognitive impairment in this study suggests that screening for dementia in healthy older adults will not reveal cognitive deficits linked to SDB. 28 In addition, correlation analyses of CASI score (and categorical data analyses to check for nonlinear trends) with other aspects of SDB-including number of arousals per hour, time spent in apneas and hypopneas, and percentage of sleep time with oxygen saturation less than 90%-also revealed no significant associations. However, men with low CASI scores had lower sleep efficiencies than did men with higher scores; their mean time in bed was about 20 minutes longer, while their mean time asleep was equivalent. Spending more time in bed is a common change in sleep behavior associated with the onset of AD and other dementias. 29 Previously, we reported that daytime sleepiness among these men was associated with both the prevalence and the incidence of dementia. 30, 31 The cross-sectional data in the current analysis showed that nondemented persons with daytime drowsiness (ESS>10) were at greater risk of having SDB but not of an increased risk of poor performance on the CASI. In contrast, among men with a diagnosis of dementia (N=113), daytime drowsiness was strongly associated with lower CASI scores, and this association may have explained earlier findings that were based on the self-report of being sleepy during the day and did not include PSG findings. Thus, daytime sleepiness may indicate either undiagnosed SDB or undiagnosed AD or other dementias. 24 Cross-sectional epidemiologic data are subject to several limitations that may bias findings, especially in older populations. Selective survival and healthy-participant effects may influence the results of studies based on participants who survive into late life and also consent to participate in studies such as the HHP's seventh examination. Such influences may obscure true associations or generate findings that would not be found in the general population. An additional healthy-participant effect also may come from the low PSG response rate in which only about half of the eligible participants consented to a sleep study, a population that tended to be healthier and more cognitively functional than those who did not participate. The PSG response rate in this study is consistent with the response rates for PSG in the SHHS and other community-based epidemiologic studies of sleep. 25, 1 Thus, these sources of healthy-participant effects in this study may have substantially biased the results toward a finding of no association between SDB and cognitive function measured by the CASI. In addition, since the CASI was developed specifically as a screening test for dementia, it may not be well suited to detect the type of deficits likely to be associated with SDB. More extensive and diverse neuropsychologic testing could register these deficits in older adults. The eighth examination, currently in progress, will include a more extensive battery of neuropsychologic tests and will provide further opportunity to investigate this relationship.
Although screening for dementia may not detect cognitive deficits that may stem from untreated severe SDB in elderly persons, this sleep disorder may still compromise daily alertness and attentiveness from associated excessive drowsiness. Continuous positive airway pressure therapy has been shown to reduce daytime sleepiness 32 and, therefore, may improve day-to-day cognitive function above the levels measured by the CASI or other standardized screening tools for dementia. However, aside from excessive drowsiness, the range of benefits from treating SDB and the consequences of untreated SDB in older adults still remains unclear because of a paucity of epidemiologic and clinical studies. Thus, it is possible that diagnosing and treating severe SDB in older adults may improve their cognitive abilities on a daily basis, but supporting evidence from epidemiologic and clinical studies of older adults are not yet available and need to be addressed in future studies of SDB in this population.
